Blood lymphocytes after radiation therapy of carcinoma of prostate and urinary bladder.
D000368:Aged; D001402:B-Lymphocytes / Q000276:immunology / Q000528:radiation effects; D003037:Cobalt Radioisotopes / Q000627:therapeutic use; D005260:Female; D006801:Humans; D007104:Immune Adherence Reaction; D037102:Lectins / Q000494:pharmacology; D007958:Leukocyte Count; D008213:Lymphocyte Activation / Q000528:radiation effects*; D007959:Lymphocyte Culture Test, Mixed; D008297:Male; D008875:Middle Aged; D011471:Prostatic Neoplasms / Q000097:blood / Q000276:immunology / Q000532:radiotherapy*; D011830:Radiation Effects; D011867:Radioisotope Teletherapy; D011879:Radiotherapy Dosage; D013601:T-Lymphocytes / Q000276:immunology / Q000528:radiation effects; D013997:Time Factors; D014373:Tuberculin / Q000031:analogs & derivatives / Q000494:pharmacology; D001749:Urinary Bladder Neoplasms / Q000097:blood / Q000276:immunology / Q000532:radiotherapy*
D003037:Cobalt Radioisotopes; D037102:Lectins; D014373:Tuberculin